EPIDEMIC MENINGITIS
Clinical trials for EPIDEMIC MENINGITIS explained in plain language.
Never miss a new study
Get alerted when new EPIDEMIC MENINGITIS trials appear
Sign up with your email to follow new studies for EPIDEMIC MENINGITIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New meningitis vaccine for kids shows promise in large trial
⭐️ VACCINE ⭐️ OngoingThis Phase 3 trial tests a new meningococcal conjugate vaccine in 660 healthy children aged 2-6 years. The vaccine targets four strains (A, C, Y, W135) that cause meningitis. Participants receive one shot and provide blood samples to compare immune response with a licensed vaccin…
Matched conditions: EPIDEMIC MENINGITIS
Phase: PHASE3 • Sponsor: Sinovac Biotech Co., Ltd • Aim: ⭐️ VACCINE ⭐️
Last updated Aug 12, 2026 00:00 UTC
-
New vaccine study aims to shield toddlers from deadly meningitis
⭐️ VACCINE ⭐️ OngoingThis study tests a vaccine designed to protect young children from four types of meningitis bacteria. Researchers gave the vaccine to 660 toddlers aged 6 to 23 months and will check their immune response over time. Some children will also receive a booster shot at age 3 to see if…
Matched conditions: EPIDEMIC MENINGITIS
Phase: PHASE4 • Sponsor: CanSino Biologics Inc. • Aim: ⭐️ VACCINE ⭐️
Last updated Jun 27, 2026 09:10 UTC